Werkgroep Cardiologische centra Nederland

PARALLAX (Follow-up)

A 24-week, study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction
Medicine
Entresto
Population
Heart failure
Phase
III
Starting year
2017
More information
Clinicaltrials.gov